Disseminierte intravaskuläre Gerinnung und Kreislaufschock

LITERATUR
1 Bill M., Palinski W., Matthias F. R. Prostaglandine in Thrombozyten nach Gabe von Catecholaminen Yerh. Dtsch. Ges. inn. Med. 1979; 85: 769
2 Gerrard J. M., White J. G., Peterson D. A. The platelet tubular system: its relationship to prostaglandin synthesis and calcium flux. Thrombos. Haemostas. 1978; 40: 224
3 Hardaway R. M., James P. M., Anderson R. S., Bredenberg E. C., West R. L. Intensive study and treatment of shock in man. J. Amer. med. Ass. 1967; 199: 779.
4 Heene D. L. Clinical and laboratory diagnosis of the hemostatic defect in shock. Microcirculation, Hemostasis and Shock 1970. p. 103. Schattauer, Stuttgart; New York:
5 Heene D. L., Matthias F. R. Adsorption of fibrinogen derivatives on insolubilized fibrinogen and fibrinmonomer. Thrombos. Res. 2: 137 1973;
6 Heene D. L., Lasch H. G., Matthias F. R. Gerinnungsstörungen und Verbrauchskoa-gulopathie bei polytraumatisierten Patienten. Intensivbehandlung 1976; 1: 42.
7 Heene D. L. Disseminated intravascular coagulation: evaluation of therapeutic approaches. Sem. Thromb. Hemostas. 1977; 3: 291.
8 Kuhn W., Graeff H. Gerinnungsstörungen in der Geburtshilfe. Thieme, Stuttgart 1977
9 Lasch H. G., Krecke H. J., Rodriguez-Erdmann F., Sessner H. H., Schütterle G. Verbrauchskoagulopathien (Pathogenese und Therapie). Fol. haemat. N. F. 1961; 6: 326.
10 Lasch H. G., Mechelke K., Nusser E., Dacud F. Der Einfluß der Fibrinolyse auf den Verlauf des hämorrhagischen Schocks. Klin. Wschr. 1961; 39: 1137.
11 Lasch H. G., Heene D. L., Huth K., Sandritter W. Pathophysiology clinical manifestations and therapy of consumption-coa-gulopathy (» Verbrauchskoagulopathie«). Amer. J. Cardiol. 1967; 20: 381.
12 Lasch H. G. Therapeutic aspects of disseminated intravascular coagulation. Thrombos. Diathes. Haemorrh. Suppl. 1969; 36: 281.
13 Lasch H. G., Huth K., Heene D. L., Müller-Berghaus G., Hörder M. -H., Janza-rik H., Mittermayer C., Sandritter W. Die Klinik der Verbrauchskoagulopathie. Dtsch. med. Wschr. 1971; 96: 715.
14 Lasch H. G., Müller-Berghaus G. ProKontra: Verbrauchskoagulopathie - Heparinbehandlung. Internist 1980; 21: 382.
15 Lasch H. G., Oehler G. Disseminated intravascular coagulation. Schattauer, Stuttgart; New York: (in press)
16 Leroux B., Rose J. P., Potron G. Traitement de la maladie des membranes hyalines par l'association plasminogene urokinase. Nouv. Presse Med. 1976; 5: 699.
17 Ludwig H. Thrombolytic therapy in pregnancy - experimental and clinical studies. In Mammen E. F., Anderson G. F., Bernhardt M. (eds.) Thrombolytic therapy p. 243. Schattauer; Stuttgart: 1971
18 Matthias F. R., Reinicke R., Heene D. L. Affinity chromatography and quantitation of soluble fibrin from plasma. Thrombos. Res. 10: 365 1977;
19 Matthias F. R., Müller W., Ganssert S. Cyclisches 3' 5'-AMP und Thrombozyten-funktion bei Patienten mit Kreislaufinsuffizienz und Schock. In Heene D. L. (Hrsg.) Immunologische Probleme der Blutgerinnung - von Willebrand-Syndrom. 1978: S. 285. Schattauer; Stuttgart, New York:
20 Matthias F. R. Soluble plasma fibrin and platelet prostaglandin endoperoxides following myocardial infarction. Haemostasis 1978; 7: 273.
21 McKay D. G. Disseminated intravascular coagulation. An intermediary mechanism of 'disease. Hoeper Harper and Row; New York: 1964
22 McKay D. G., Müller-Berghaus G., Cruse V. Activation of Hageman factor by elagic acid and the generalized Shwartzman reaction. Amer. J. Path. 1969; 54: 393.
23 McKay D. G., Linder M. M., Gruse V. K. Mechanism of thrombosis of the microcirculation. Amer. J. Path. 1971; 63: 231.
24 Miller R. D., Robbins T. O., Tong M. J., Barton S. L. Coagulation defects associated with massive blood transfusions. Ann. Surg. 1971; 174: 794.
25 Miller R. D. Complications of massive blood transfusions. Anesthesiology 1973; 39: 82.
26 Mittermayer Ch., Riede U. N., Bleyl U., Herzog H., v. Wiechert P., Riesner K. Schocklunge. Verb. Dtsch. Ges. Path. 1978; 62: 11.
27 Müller-Berghaus G., McKay D. G. Pre vention of the generalized Shwartzrnan re action in pregnant rats by A-adrenergic blocking agents. Lab. Invest. 1967; 17: 276.
28 Neuhof H., Hey D., Glaser E., Wolf H., Lasch H. G. Hemodynamic reactions induced by streptokinase therapy in patients with acute myocardial infarction. Europ. J. Intensive Care Medicine 1975; 1: 27.
29 Neuhof H., Wolf H. Method for continuously measured oxygen consumption and cardiac output for use in critically ill patients. Critical Care Medicine 1978; 6: 155.
30 Reinicke R., Matthias F. R., Lasch H. G. Content of soluble fibrin in plasma of patients after myocardial infarction. with carcinomas and consumption coagulopathy. Thrombos. Res. 1977; 11: 365.
31 Saldeen T. The microembolism syndrom. Microvasc. Res. 1976; 11: 227.
32 Saldeen T. The macroembolsm syndrom: a review. In Saldeen T. (ed.) The Micro-embolism. p. 7. Almquist and Wiksell International; Stockholm: 1979
33 Sandritter W., Lasch H. G. Pathologic aspects of shock. Meth. Achiev. exp. Path. 1967; 3: 86.
34 Selye H. Thrombohemorrhagic phenomenon. Charles C. Thomas, Springfield Ill. 1966
35 Straub P. W. Pro - Kontra: Verbrauchs-koagulopathie - Heparinbehandlung. Internist 1980; 21: 385.